- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 7 - Increased Monetary Costs of Multiple Sclerosis
During this segment, the panelists discuss the how the trend toward outpatient care and development of disease-modifying therapies for the treatment of multiple sclerosis (MS) has affected costs of care.
Leslie Fish, PharmD, explains that because most treatment options for MS are available through the pharmaceutical side, the costs of medications and entire cost of treatment for MS has risen dramatically since 2010.
Gary M. Owens, MD, agrees and explains a 3 year analysis that compared the direct medical costs of MS to pharmaceutical costs and revealed that 85% of the expenditures for the treatment of MS result on the pharmaceutical side.
Dr Fish continues by explaining how the decrease in the number of hospitalizations is relative to the trend to treat MS in an outpatient care setting.
The panelists conclude the discussion with concerns that as the treatment costs for MS continue to rise, many aspects of treatment aren’t covered, which leaves a huge burden on patients, their caregivers, and family members.
The Joint Commission is launching the Rural Health Clinic Accreditation Program to standardize staff training and patient care practices at rural health clinics nationwide; the American Cancer Society recently launched the largest-ever study of cancer risk and outcomes in Black women; the HHS COVID-19 vaccination campaign saved $732 billion by preventing illness and related costs.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
